Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8QH8

Human Carbonic Anhydrase II in complex with Lasamide (2,4-Dichloro 5-sulfamoyl benzoic acid)

Summary for 8QH8
Entry DOI10.2210/pdb8qh8/pdb
DescriptorCarbonic anhydrase 2, ZINC ION, 2,4-dichloro-5-sulfamoylbenzoic acid, ... (4 entities in total)
Functional Keywordsmetalloenzyme, lyase, inhibitor
Biological sourceHomo sapiens (human)
Total number of polymer chains1
Total formula weight29624.56
Authors
Baroni, C.,Ferraroni, M.,Carta, F. (deposition date: 2023-09-06, release date: 2024-09-18, Last modification date: 2025-10-01)
Primary citationBaroni, C.,D'Agostino, I.,Renzi, G.,Kilbile, J.T.,Tamboli, Y.,Ferraroni, M.,Carradori, S.,Capasso, C.,Carta, F.,Supuran, C.T.
Lasamide, a Potent Human Carbonic Anhydrase Inhibitor from the Market: Inhibition Profiling and Crystallographic Studies.
Acs Med.Chem.Lett., 15:1749-1755, 2024
Cited by
PubMed Abstract: Lasamide is a synthetic precursor and a contaminant of the diuretic Furosemide manufacturing process and represents a highly valuable building block for fragment-based drug discovery approaches. We assessed the ability of Lasamide to inhibit in vitro the human-expressed Carbonic Anhydrases by means of the stopped-flow technique, and we assessed its binding modes within hCAs II and XII-mimic catalytic clefts by X-ray crystallography. Interestingly, an unprecedented crystal form for the hCA IX mimic H-tag is reported and discussed herein.
PubMed: 39411526
DOI: 10.1021/acsmedchemlett.4c00341
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.04 Å)
Structure validation

251801

PDB entries from 2026-04-08

PDB statisticsPDBj update infoContact PDBjnumon